275 related articles for article (PubMed ID: 35690506)
1. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma.
Wang L
Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506
[TBL] [Abstract][Full Text] [Related]
2. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract][Full Text] [Related]
3. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
[TBL] [Abstract][Full Text] [Related]
4. CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma.
Yang Y; Yan C; Chen XJ
BMC Oral Health; 2023 Oct; 23(1):724. PubMed ID: 37803318
[TBL] [Abstract][Full Text] [Related]
5. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
[TBL] [Abstract][Full Text] [Related]
6. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
8. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.
He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672
[TBL] [Abstract][Full Text] [Related]
10. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
Hu R; Lu M; She L
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication of xenotropic and polytropic retrovirus receptor 1 in papillary thyroid carcinoma.
Zou H; Xiang C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):90-96. PubMed ID: 34117845
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
16. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
[TBL] [Abstract][Full Text] [Related]
19. IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis.
Li H; Ye M; Hu Z; Lu H; Zheng D; Wu M; Ge T; Xu S; Ge Z; Zhang S; Xu G; Chen H
Medicine (Baltimore); 2023 Mar; 102(11):e33124. PubMed ID: 36930079
[TBL] [Abstract][Full Text] [Related]
20. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
